Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trialCharles S. Fuchs, Francesco Di Costanzo, Alejandro Molina Alavez et al.|The Lancet Oncology|2019Cited by 282
Neo-adjuvant and adjuvant chemotherapy of gastric cancerFerdinando De Vita, Michele Orditura, Francesco Giuliani et al.|Annals of Oncology|2007Cited by 63
Impact of a Cardio-Oncology Unit on Prevention of Cardiovascular Events in Cancer PatientsAlessandra Cuomo, Carlo G. Tocchetti, Valentina Mercurio et al.|ESC Heart Failure|2022Cited by 22
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor PrognosisFrancesco Iovino, Michele Orditura, Anna Diana et al.|Journal of Clinical Medicine|2022Cited by 13
Enhanced Antitumor Effect of Trastuzumab and Duligotuzumab or Ipatasertib Combination in HER-2 Positive Gastric Cancer CellsMaria Maddalena Laterza, Ferdinando De Vita|Cancers|2021Cited by 7